DNA-PK inhibition enhances neoantigen diversity and increases T cell responses to immunoresistant tumors is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0.509. It has been cited 11 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.136
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
National Cancer Institute
Grant: R01CA271537
National Cancer Institute
Grant: R01CA207913
National Cancer Institute
Grant: P30CA046934
Department of Veteran Affairs
Grant: BX004935
BLRD VA
Grant: I01 BX004935
Fields of Study
MeSH Terms
Keywords